🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Prophylactic use of aromatase inhibitor is effective in decreasing the inci...
Status
Unknown
Location
Mohamed ALI Alabiad
Start Date
2020-06-01
Trial ID
NCT05203562
Treatments Being Tested
AMBRE is a phase III study comparing two standard treatments as initial met...
Status
Active Not Recruiting
Location
Centre Hospitalier Lyon Sud
Start Date
2020-06-11
Trial ID
NCT04158362
This study aims to evaluate the safety, tolerability, efficacy and pharmaco...
Status
Recruiting
Location
The Second Affiliated Hospital of Dalian Medical University
Start Date
2026-03-27
Trial ID
NCT07389733
Treatments Being Tested
Primary Objective: To determine whether amcenestrant per overall survival ...
Status
Terminated
Location
Alabama Oncology - St. Vincent's Birmingham- Site Number : 8400008
Start Date
2019-10-22
Trial ID
NCT04059484
Treatments Being Tested
The present multi-center, open-label, single-arm study aims to evaluate the...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-06
Trial ID
NCT01626222
Treatments Being Tested
Men and post- or induced menopausal women with ER\[+\] and/or PgR\[+\], HER...
Status
Completed
Location
Hospital General Universitario de Alicante
Start Date
2020-10-23
Trial ID
NCT04300790
Treatments Being Tested
The purpose of this study is to learn about the effects of the study medici...
Status
Completed
Location
Advocate Good Shepherd Hospital
Start Date
2024-07-11
Trial ID
NCT06465368
Treatments Being Tested
A study of palbociclib in combination with letrozole as treatment of post-m...
Status
Completed
Location
Benjamin Carl Forster
Start Date
2016-03-09
Trial ID
NCT02679755
Treatments Being Tested
POLAR is a phase III clinical trial, which will test the safety and efficac...
Status
Active Not Recruiting
Location
Medizinische Universität Graz (MUG)
Start Date
2019-08-27
Trial ID
NCT03820830
Treatments Being Tested
The goal of this open-label dose escalation and expansion study is to evalu...
Status
Recruiting
Location
City of Hope
Start Date
2025-03-25
Trial ID
NCT07029399
Treatments Being Tested